— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
How H1N1 differs from other viruses as a respiratory illness
The 2009/2010 Influenza A (H1N1) is one of several viruses responsible for respiratory-related infections. A new study from Rhode Island Hospital examined patients with viruses and found distinguishing characteristics of the H1N1 virus in how it affects respiratory illness. Their findings will be presented at the annual meeting of the Infectious Diseases Society of America to be held in Vancouver, Canada on Friday, Oct. 22.
Phil Chan, MD, an infectious diseases fellow at Rhode Island Hospital, studied the signs, symptoms, and laboratory findings of 668 adult and paediatric patients who were treated at Rhode Island Hospital or its partner, The Miriam Hospital, between October and December 2009 with a confirmed viral infection.
Chan says, 'Compared to patients with other viruses, individuals with novel Influenza A, or H1N1, were more likely to present with subjective fever, cough, sore throat, nausea/vomiting. The mean white blood count of patients with H1N1 is lower than with other viruses as well.'
Leonard Mermel, DO, medical director of epidemiology and infection control at Rhode Island Hospital and professor of medicine at The Warren Alpert Medical School of Brown University, is a co-author. Mermel adds, 'Perhaps more striking is that patients with the novel Influenza A virus may have higher mortality rates compared to other respiratory viruses in the patients studied. As a result of this study, and based on available data in the literature, we recommend that high-risk patients infected with novel Influenza A receive expedient antiviral therapy.' Mermel is also a physician with University Medicine.
In his presentation, Chan will provide more details on the findings of this study.
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Researchers at IRB Barcelona produce more data on key genes in diabetes
Alzheimer's disease breakthrough
Alzheimer's gene slows export of toxic amyloid-beta protein
Nanoparticles deliver their cargo, then disappear